DNAJC18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.454200E-01
Normal-vs-Stage2
4.959200E-01
Normal-vs-Stage3
2.013800E-01
Normal-vs-Stage4
6.852400E-01
Stage1-vs-Stage2
1.967010E-01
Stage1-vs-Stage3
1.812180E-01
Stage1-vs-Stage4
7.645600E-01
Stage2-vs-Stage3
5.446200E-01
Stage2-vs-Stage4
1.503410E-01
Stage3-vs-Stage4
2.191400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.031000E-01
Normal-vs-AfricanAmerican
8.427000E-01
Normal-vs-Asian
3.267600E-01
Caucasian-vs-AfricanAmerican
9.310200E-01
Caucasian-vs-Asian
1.659600E-01
AfricanAmerican-vs-Asian
5.037200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.196600E-01
Normal-vs-Female
9.804800E-01
Male-vs-Female
3.964800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.067200E-01
Normal-vs-Age(41-60Yrs)
7.866400E-01
Normal-vs-Age(61-80Yrs)
7.682600E-01
Normal-vs-Age(81-100Yrs)
7.645500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.477400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.428200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.672000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.124100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.398600E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.276400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.434500E-02
Normal-vs-Daily Drinker
5.603600E-01
Normal-vs-Weekly Drinker
6.307200E-01
Normal-vs-Occasional Drinker
8.663400E-01
Normal-vs-Social Drinker
4.884800E-01
Non Drinker-vs-Daily Drinker
3.892400E-01
Non Drinker-vs-Weekly Drinker
9.488000E-02
Non Drinker-vs-Occasional Drinker
5.282000E-02
Non Drinker-vs-Social Drinker
5.996200E-02
Daily Drinker-vs-Weekly Drinker
6.694600E-01
Daily Drinker-vs-Occasional Drinker
2.012400E-01
Daily Drinker-vs-Social Drinker
1.320770E-01
Weekly Drinker-vs-Occasional Drinker
3.571400E-01
Weekly Drinker-vs-Social Drinker
2.656400E-01
Occasional Drinker-vs-Social Drinker
7.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.390400E-01
Normal-vs-Grade 2
3.858800E-01
Normal-vs-Grade 3
4.306200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.723900E-02
Grade 1-vs-Grade 3
4.810100E-02
Grade 1-vs-Grade 4
4.390400E-01
Grade 2-vs-Grade 3
4.677200E-01
Grade 2-vs-Grade 4
3.858800E-01
Grade 3-vs-Grade 4
4.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.259600E-01
Normal-vs-NonDiabetic
9.011200E-01
Diabetic-vs-NonDiabetic
4.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.382200E-01
Normal-vs-NoPancreatitis
8.896800E-01
Pancreatitis-vs-NoPancreatitis
2.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.877600E-01
Normal-vs-N1
5.376600E-01
N0-vs-N1
1.035020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.705810E-01
Normal-vs-TP53-NonMutant
2.376600E-01
TP53-Mutant-vs-TP53-NonMutant
3.199700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
